RT Journal Article
SR Electronic
T1 A Scoping Review of Privacy and Utility Metrics in Medical Synthetic Data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.28.23299124
DO 10.1101/2023.11.28.23299124
A1 Kaabachi, Bayrem
A1 Despraz, Jérémie
A1 Meurers, Thierry
A1 Otte, Karen
A1 Halilovic, Mehmed
A1 Kulynych, Bogdan
A1 Prasser, Fabian
A1 Raisaro, Jean Louis
YR 2024
UL http://medrxiv.org/content/early/2024/08/28/2023.11.28.23299124.abstract
AB The use of synthetic data is a promising solution to facilitate the sharing and reuse of health-related data beyond its initial collection while addressing privacy concerns. However, there is still no consensus on a standardized approach for systematically evaluating the privacy and utility of synthetic data, impeding its broader adoption. In this work, we present a comprehensive review and systematization of current methods for evaluating synthetic health-related data, focusing on both privacy and utility aspects. Our findings suggest that there are a variety of methods for assessing the utility of synthetic data, but no consensus on which method is optimal in which scenario. Moreover, we found that most studies included in this review do not evaluate the privacy protection provided by synthetic data, and those that do often significantly underestimate the risks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.